Pfizer projects it will generate record-high revenue in 2022, saying Tuesday it expects to sell $32 billion of its Covid-19 shots and $22 billion of its antiviral coronavirus treatment pill Paxlovid … [+2442 chars]
Pfizer expects $54 billion in 2022 sales on Covid vaccine and treatment pill – CNBC